vegfr1 Search Results


94
Miltenyi Biotec reafinitytm
Reafinitytm, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vegfr1/VEGFR-1+(Flt-1)+Antibody%2C+anti-human%2C+REAfinity/pmc13004120-86-20-22
Average 94 stars, based on 1 article reviews
reafinitytm - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

93
R&D Systems duoset human vegf r1 flt 1
Duoset Human Vegf R1 Flt 1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vegfr1/Human+VEGFR1%2FFlt-1+DuoSet+ELISA/pm28500309-67-14-23
Average 93 stars, based on 1 article reviews
duoset human vegf r1 flt 1 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
R&D Systems dvr100b
Dvr100b, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vegfr1/Human+VEGFR1%2FFlt-1+Quantikine+ELISA+Kit/pmc02958153-43-24-25
Average 93 stars, based on 1 article reviews
dvr100b - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

94
R&D Systems vegfr 1 blocking antibody
Vegfr 1 Blocking Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vegfr1/Mouse+VEGFR1%2FFlt-1+Antibody/10__1177_slash_1933719114528275-17470-3-7
Average 94 stars, based on 1 article reviews
vegfr 1 blocking antibody - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

92
R&D Systems anti p vegfr 1 antibody
Anti P Vegfr 1 Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vegfr1/Human+Phospho-VEGFR1%2FFlt-1+(Y1213)+Antibody/us12441765-167-1-3
Average 92 stars, based on 1 article reviews
anti p vegfr 1 antibody - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

93
R&D Systems αvegfr1
( A ) Schematic of transendothelial transport assay. ( B ) Representative images of BODIPY-C16 (green) in LLC tumor cells after 1 hour. VEGFR1-Fc was used in control samples to bind tumor cell–derived VEGF-B. Endothelial cells act as a physical barrier for BODIPY-C16 access, demonstrated in a representative image from an endothelial cell–free control (“No ECs”). A control performed without tumor cells (“No TCs”) is shown to confirm removal of endothelial cells prior to fluorescence imaging of basolateral tumor cells. Scale bar: 100 μm. ( C ) BODIPY-C16 fluorescence in LLC tumor cells, normalized to WT plus VEGFR1-Fc control ( n = 3 per group). ( D ) Representative confocal images of WT or Rptor -KO endothelial cells treated with BODIPY-C16 for 5 minutes. Nuclear (Hoechst, blue) and actin (phalloidin, red) staining was used to detect perinuclear and cell boundaries, respectively. Total (all z -planes) and basolateral (bottom 10% of z -planes) BODIPY-C16 (green) staining are also shown, with the basolateral BODIPY presented at higher exposure (HE). Scale bar: 20 μm. BODIPY-C16 intensities at the basolateral surface were normalized to total signal in each cell. WT ( n = 16) and Rptor -KO ( n = 10) cells were analyzed from 2 independent experiments. ( E and F ) WT ( n = 4) or Rptor ECKO ( n = 5) mice were inoculated with LLC tumor cells as described in  A. One hour prior to tumor harvest, animals were injected with BODIPY-C16 (50 μg). Median fluorescence intensity (MFI) was determined by flow cytometry in ( E ) CD45 – CD31 + endothelial cells and ( F ) CD45 – EpCAM + FSC hi tumor cell–enriched populations and normalized to littermate WT controls. * P < 0.05, ** P < 0.01, *** P < 0.005, **** P < 0.001 by 2-way ANOVA with Tukey’s post hoc test ( B ) or unpaired, 2-tailed Student’s t test ( D – F ).
αvegfr1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vegfr1/Mouse+VEGFR1%2FFlt-1+Antibody/pmc12128997-228-19-20
Average 93 stars, based on 1 article reviews
αvegfr1 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

94
Proteintech anti flt1 antibody
Fig. 10 Diagram of the hypothesis mechanism of tsRNA-3043a facilitates POF by inhibiting <t>FLT1</t>
Anti Flt1 Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vegfr1/VEGFR-1%2FFLT-1+Antibody/pm39343854-104-11-15
Average 94 stars, based on 1 article reviews
anti flt1 antibody - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

93
Proteintech ke00113
Fig. 10 Diagram of the hypothesis mechanism of tsRNA-3043a facilitates POF by inhibiting <t>FLT1</t>
Ke00113, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vegfr1/Human+VEGFR-1+ELISA+Kit/pmc12457690-61-8-5
Average 93 stars, based on 1 article reviews
ke00113 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

94
Santa Cruz Biotechnology vegfr
Fig. 10 Diagram of the hypothesis mechanism of tsRNA-3043a facilitates POF by inhibiting <t>FLT1</t>
Vegfr, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vegfr1/VEGFR1+Antibody/10__1161_slash_01__res__0000260179__43672__fe-31-13-14
Average 94 stars, based on 1 article reviews
vegfr - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

92
R&D Systems duoset human vegf r1 flt 1 kit
Fig. 10 Diagram of the hypothesis mechanism of tsRNA-3043a facilitates POF by inhibiting <t>FLT1</t>
Duoset Human Vegf R1 Flt 1 Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vegfr1/Human+VEGFR1%2FFlt-1+ELISA+Kit+(Colorimetric)/pmc09495588-84-20-31
Average 92 stars, based on 1 article reviews
duoset human vegf r1 flt 1 kit - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

93
R&D Systems quantikine human vegf immunoassay
Fig. 10 Diagram of the hypothesis mechanism of tsRNA-3043a facilitates POF by inhibiting <t>FLT1</t>
Quantikine Human Vegf Immunoassay, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vegfr1/Quantikine+Immunoassay+Control+Group+239+for+Human+VEGFR1/pmc03857635-182-33-37
Average 93 stars, based on 1 article reviews
quantikine human vegf immunoassay - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

92
Elabscience Biotechnology rat elisa kit
Fig. 10 Diagram of the hypothesis mechanism of tsRNA-3043a facilitates POF by inhibiting <t>FLT1</t>
Rat Elisa Kit, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vegfr1/Rat+VEGFR1%2FFLT1+(Vascular+Endothelial+Growth+Factor+Receptor+1)+ELISA+Kit/pmc07428417-47-45-48
Average 92 stars, based on 1 article reviews
rat elisa kit - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

Image Search Results


( A ) Schematic of transendothelial transport assay. ( B ) Representative images of BODIPY-C16 (green) in LLC tumor cells after 1 hour. VEGFR1-Fc was used in control samples to bind tumor cell–derived VEGF-B. Endothelial cells act as a physical barrier for BODIPY-C16 access, demonstrated in a representative image from an endothelial cell–free control (“No ECs”). A control performed without tumor cells (“No TCs”) is shown to confirm removal of endothelial cells prior to fluorescence imaging of basolateral tumor cells. Scale bar: 100 μm. ( C ) BODIPY-C16 fluorescence in LLC tumor cells, normalized to WT plus VEGFR1-Fc control ( n = 3 per group). ( D ) Representative confocal images of WT or Rptor -KO endothelial cells treated with BODIPY-C16 for 5 minutes. Nuclear (Hoechst, blue) and actin (phalloidin, red) staining was used to detect perinuclear and cell boundaries, respectively. Total (all z -planes) and basolateral (bottom 10% of z -planes) BODIPY-C16 (green) staining are also shown, with the basolateral BODIPY presented at higher exposure (HE). Scale bar: 20 μm. BODIPY-C16 intensities at the basolateral surface were normalized to total signal in each cell. WT ( n = 16) and Rptor -KO ( n = 10) cells were analyzed from 2 independent experiments. ( E and F ) WT ( n = 4) or Rptor ECKO ( n = 5) mice were inoculated with LLC tumor cells as described in  A. One hour prior to tumor harvest, animals were injected with BODIPY-C16 (50 μg). Median fluorescence intensity (MFI) was determined by flow cytometry in ( E ) CD45 – CD31 + endothelial cells and ( F ) CD45 – EpCAM + FSC hi tumor cell–enriched populations and normalized to littermate WT controls. * P < 0.05, ** P < 0.01, *** P < 0.005, **** P < 0.001 by 2-way ANOVA with Tukey’s post hoc test ( B ) or unpaired, 2-tailed Student’s t test ( D – F ).

Journal: JCI Insight

Article Title: Increased fatty acid delivery by tumor endothelium promotes metastatic outgrowth

doi: 10.1172/jci.insight.187531

Figure Lengend Snippet: ( A ) Schematic of transendothelial transport assay. ( B ) Representative images of BODIPY-C16 (green) in LLC tumor cells after 1 hour. VEGFR1-Fc was used in control samples to bind tumor cell–derived VEGF-B. Endothelial cells act as a physical barrier for BODIPY-C16 access, demonstrated in a representative image from an endothelial cell–free control (“No ECs”). A control performed without tumor cells (“No TCs”) is shown to confirm removal of endothelial cells prior to fluorescence imaging of basolateral tumor cells. Scale bar: 100 μm. ( C ) BODIPY-C16 fluorescence in LLC tumor cells, normalized to WT plus VEGFR1-Fc control ( n = 3 per group). ( D ) Representative confocal images of WT or Rptor -KO endothelial cells treated with BODIPY-C16 for 5 minutes. Nuclear (Hoechst, blue) and actin (phalloidin, red) staining was used to detect perinuclear and cell boundaries, respectively. Total (all z -planes) and basolateral (bottom 10% of z -planes) BODIPY-C16 (green) staining are also shown, with the basolateral BODIPY presented at higher exposure (HE). Scale bar: 20 μm. BODIPY-C16 intensities at the basolateral surface were normalized to total signal in each cell. WT ( n = 16) and Rptor -KO ( n = 10) cells were analyzed from 2 independent experiments. ( E and F ) WT ( n = 4) or Rptor ECKO ( n = 5) mice were inoculated with LLC tumor cells as described in A. One hour prior to tumor harvest, animals were injected with BODIPY-C16 (50 μg). Median fluorescence intensity (MFI) was determined by flow cytometry in ( E ) CD45 – CD31 + endothelial cells and ( F ) CD45 – EpCAM + FSC hi tumor cell–enriched populations and normalized to littermate WT controls. * P < 0.05, ** P < 0.01, *** P < 0.005, **** P < 0.001 by 2-way ANOVA with Tukey’s post hoc test ( B ) or unpaired, 2-tailed Student’s t test ( D – F ).

Article Snippet: For VEGFR1 neutralization in vivo, animals were treated with 2.5 mg/kg of normal rabbit IgG (R&D Systems, AB-108-C) or αVEGFR1 (R&D Systems, AF471) every 3–4 days by i.p. injection.

Techniques: Transport Assay, Control, Derivative Assay, Fluorescence, Imaging, Staining, Injection, Flow Cytometry

Fig. 10 Diagram of the hypothesis mechanism of tsRNA-3043a facilitates POF by inhibiting FLT1

Journal: Journal of molecular histology

Article Title: tsRNA-3043a intensifies apoptosis and senescence of ovarian granulosa cells to drive premature ovarian failure by targeting FLT1.

doi: 10.1007/s10735-024-10256-8

Figure Lengend Snippet: Fig. 10 Diagram of the hypothesis mechanism of tsRNA-3043a facilitates POF by inhibiting FLT1

Article Snippet: The sections were blocked with 5% BSA and incubated with the anti-FLT1 antibody (1:200, 13687-1-AP, Proteintech) overnight at 4°C.

Techniques: